April 13, 2021 — The FDA and CDC on Tuesday advisable that use of the Johnson & Johnson COVID-19 vaccine be paused after studies of blood clots in sufferers receiving the shot, the FDA and CDC introduced Tuesday.
In a press release, FDA mentioned 6.8 million doses of the J&J vaccine have been administered and the company is investigating six reported instances of a uncommon and extreme blood clot occurring in sufferers who obtained the vaccine.
The CDC will convene a gathering of the Advisory Committee on Immunization Practices on Wednesday to assessment the instances.
“That is essential to make sure that the well being care supplier group is conscious of the potential for these opposed results and might plan because of the distinctive therapy required with this sort of blood clot,” the FDA mentioned on Twitter.
The company plans a ten a.m. information convention to debate the state of affairs additional. Examine again for extra protection.